Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study
- 6 May 2019
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 22 (6) , 1176-1182
Abstract
Lymphovascular invasion (LVI) is a strong predictive factor for lymph node metastasis (LNM) in early gastric cancer (GC). This study investigated the risk for LNM in pT1b GC without LVI based on Epstein–Barr virus (EBV) status in addition to conventional clinicopathological parameters.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP16K08661)
- Daiwa Securities Health Foundation (None)
This publication has 26 references indexed in Scilit:
- A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: “eCura system”American Journal of Gastroenterology, 2017
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)Gastric Cancer, 2016
- Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancerJournal of Gastroenterology, 2016
- Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancerDigestive Endoscopy, 2015
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancerGastric Cancer, 2009
- Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinomaCancer Science, 2008
- Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis.1998
- Clinicopathological characteristics of gastric cancer in the elderlyBritish Journal of Cancer, 1996
- Gastric cancer in elderly patients--results of surgical treatment.1989